Connect with us

Uncategorized

Unleashing the power of AI to track animal behavior

LA JOLLA (September 26, 2023)—Movement offers a window into how the brain operates and controls the body. From clipboard-and-pen observation to modern…

Published

on

LA JOLLA (September 26, 2023)—Movement offers a window into how the brain operates and controls the body. From clipboard-and-pen observation to modern artificial intelligence-based techniques, tracking human and animal movement has come a long way. Current cutting-edge methods utilize artificial intelligence to automatically track parts of the body as they move. However, training these models is still time-intensive and limited by the need for researchers to manually mark each body part hundreds to thousands of times.

Credit: Salk Institute

LA JOLLA (September 26, 2023)—Movement offers a window into how the brain operates and controls the body. From clipboard-and-pen observation to modern artificial intelligence-based techniques, tracking human and animal movement has come a long way. Current cutting-edge methods utilize artificial intelligence to automatically track parts of the body as they move. However, training these models is still time-intensive and limited by the need for researchers to manually mark each body part hundreds to thousands of times.

Now, Associate Professor Eiman Azim and team have created GlowTrack, a non-invasive movement tracking method that uses fluorescent dye markers to train artificial intelligence. GlowTrack is robust, time-efficient, and high definition—capable of tracking a single digit on a mouse’s paw or hundreds of landmarks on a human hand.

The technique, published in Nature Communications on September 26, 2023, has applications spanning from biology to robotics to medicine and beyond.

“Over the last several years, there has been a revolution in tracking behavior as powerful artificial intelligence tools have been brought into the laboratory,” says Azim, senior author and holder of the William Scandling Developmental Chair. “Our approach makes these tools more versatile, improving the ways we capture diverse movements in the laboratory. Better quantification of movement gives us better insight into how the brain controls behavior and could aid in the study of movement disorders like amyotrophic lateral sclerosis (ALS) and Parkinson’s disease.”

Current methods to capture animal movement often require researchers to manually and repeatedly mark body parts on a computer screen—a time-consuming process subject to human error and time constraints. Human annotation means that these methods can usually only be used in a narrow testing environment, since artificial intelligence models specialize to the limited amount of training data they receive. For example, if the light, orientation of the animal’s body, camera angle, or any number of other factors were to change, the model would no longer recognize the tracked body part.

To address these limitations, the researchers used fluorescent dye to label parts of the animal or human body. With these “invisible” fluorescent dye markers, an enormous amount of visually diverse data can be created quickly and fed into the artificial intelligence models without the need for human annotation. Once fed this robust data, these models can be used to track movements across a much more diverse set of environments and at a resolution that would be far more difficult to achieve with manual human labeling.

This opens the door for easier comparison of movement data between studies, as different laboratories can use the same models to track body movement across a variety of situations. According to Azim, comparison and reproducibility of experiments are essential in the process of scientific discovery.

“Fluorescent dye markers were the perfect solution,” says first author Daniel Butler, a Salk bioinformatics analyst.  Like the invisible ink on a dollar bill that lights up only when you want it to, our fluorescent dye markers can be turned on and off in the blink of an eye, allowing us to generate a massive amount of training data.”

In the future, the team is excited to support diverse applications of GlowTrack and pair its capabilities with other tracking tools that reconstruct movements in three dimensions, and with analysis approaches that can probe these vast movement datasets for patterns.

“Our approach can benefit a host of fields that need more sensitive, reliable, and comprehensive tools to capture and quantify movement,” says Azim. “I am eager to see how other scientists and non-scientists adopt these methods, and what unique, unforeseen applications might arise.”

Other authors include Alexander Keim and Shantanu Ray of Salk.

The work was supported by the UC San Diego CMG Training Program, a Jesse and Caryl Philips Foundation Award, the National Institutes of Health (R00NS088193, DP2NS105555, R01NS111479, RF1NS128898, and U19NS112959), the Searle Scholars Program, the Pew Charitable Trusts, and the McKnight Foundation.

About the Salk Institute for Biological Studies:

Unlocking the secrets of life itself is the driving force behind the Salk Institute. Our team of world-class, award-winning scientists pushes the boundaries of knowledge in areas such as neuroscience, cancer research, aging, immunobiology, plant biology, computational biology, and more. Founded by Jonas Salk, developer of the first safe and effective polio vaccine, the Institute is an independent, nonprofit research organization and architectural landmark: small by choice, intimate by nature, and fearless in the face of any challenge. Learn more at www.salk.edu.


Read More

Continue Reading

Uncategorized

Part 1: Current State of the Housing Market; Overview for mid-March 2024

Today, in the Calculated Risk Real Estate Newsletter: Part 1: Current State of the Housing Market; Overview for mid-March 2024
A brief excerpt: This 2-part overview for mid-March provides a snapshot of the current housing market.

I always like to star…

Published

on

Today, in the Calculated Risk Real Estate Newsletter: Part 1: Current State of the Housing Market; Overview for mid-March 2024

A brief excerpt:
This 2-part overview for mid-March provides a snapshot of the current housing market.

I always like to start with inventory, since inventory usually tells the tale!
...
Here is a graph of new listing from Realtor.com’s February 2024 Monthly Housing Market Trends Report showing new listings were up 11.3% year-over-year in February. This is still well below pre-pandemic levels. From Realtor.com:

However, providing a boost to overall inventory, sellers turned out in higher numbers this February as newly listed homes were 11.3% above last year’s levels. This marked the fourth month of increasing listing activity after a 17-month streak of decline.
Note the seasonality for new listings. December and January are seasonally the weakest months of the year for new listings, followed by February and November. New listings will be up year-over-year in 2024, but we will have to wait for the March and April data to see how close new listings are to normal levels.

There are always people that need to sell due to the so-called 3 D’s: Death, Divorce, and Disease. Also, in certain times, some homeowners will need to sell due to unemployment or excessive debt (neither is much of an issue right now).

And there are homeowners who want to sell for a number of reasons: upsizing (more babies), downsizing, moving for a new job, or moving to a nicer home or location (move-up buyers). It is some of the “want to sell” group that has been locked in with the golden handcuffs over the last couple of years, since it is financially difficult to move when your current mortgage rate is around 3%, and your new mortgage rate will be in the 6 1/2% to 7% range.

But time is a factor for this “want to sell” group, and eventually some of them will take the plunge. That is probably why we are seeing more new listings now.
There is much more in the article.

Read More

Continue Reading

Uncategorized

Pharma industry reputation remains steady at a ‘new normal’ after Covid, Harris Poll finds

The pharma industry is hanging on to reputation gains notched during the Covid-19 pandemic. Positive perception of the pharma industry is steady at 45%…

Published

on

The pharma industry is hanging on to reputation gains notched during the Covid-19 pandemic. Positive perception of the pharma industry is steady at 45% of US respondents in 2023, according to the latest Harris Poll data. That’s exactly the same as the previous year.

Pharma’s highest point was in February 2021 — as Covid vaccines began to roll out — with a 62% positive US perception, and helping the industry land at an average 55% positive sentiment at the end of the year in Harris’ 2021 annual assessment of industries. The pharma industry’s reputation hit its most recent low at 32% in 2019, but it had hovered around 30% for more than a decade prior.

Rob Jekielek

“Pharma has sustained a lot of the gains, now basically one and half times higher than pre-Covid,” said Harris Poll managing director Rob Jekielek. “There is a question mark around how sustained it will be, but right now it feels like a new normal.”

The Harris survey spans 11 global markets and covers 13 industries. Pharma perception is even better abroad, with an average 58% of respondents notching favorable sentiments in 2023, just a slight slip from 60% in each of the two previous years.

Pharma’s solid global reputation puts it in the middle of the pack among international industries, ranking higher than government at 37% positive, insurance at 48%, financial services at 51% and health insurance at 52%. Pharma ranks just behind automotive (62%), manufacturing (63%) and consumer products (63%), although it lags behind leading industries like tech at 75% positive in the first spot, followed by grocery at 67%.

The bright spotlight on the pharma industry during Covid vaccine and drug development boosted its reputation, but Jekielek said there’s maybe an argument to be made that pharma is continuing to develop innovative drugs outside that spotlight.

“When you look at pharma reputation during Covid, you have clear sense of a very dynamic industry working very quickly and getting therapies and products to market. If you’re looking at things happening now, you could argue that pharma still probably doesn’t get enough credit for its advances, for example, in oncology treatments,” he said.

Read More

Continue Reading

Uncategorized

Q4 Update: Delinquencies, Foreclosures and REO

Today, in the Calculated Risk Real Estate Newsletter: Q4 Update: Delinquencies, Foreclosures and REO
A brief excerpt: I’ve argued repeatedly that we would NOT see a surge in foreclosures that would significantly impact house prices (as happened followi…

Published

on

Today, in the Calculated Risk Real Estate Newsletter: Q4 Update: Delinquencies, Foreclosures and REO

A brief excerpt:
I’ve argued repeatedly that we would NOT see a surge in foreclosures that would significantly impact house prices (as happened following the housing bubble). The two key reasons are mortgage lending has been solid, and most homeowners have substantial equity in their homes..
...
And on mortgage rates, here is some data from the FHFA’s National Mortgage Database showing the distribution of interest rates on closed-end, fixed-rate 1-4 family mortgages outstanding at the end of each quarter since Q1 2013 through Q3 2023 (Q4 2023 data will be released in a two weeks).

This shows the surge in the percent of loans under 3%, and also under 4%, starting in early 2020 as mortgage rates declined sharply during the pandemic. Currently 22.6% of loans are under 3%, 59.4% are under 4%, and 78.7% are under 5%.

With substantial equity, and low mortgage rates (mostly at a fixed rates), few homeowners will have financial difficulties.
There is much more in the article. You can subscribe at https://calculatedrisk.substack.com/

Read More

Continue Reading

Trending